Literature DB >> 1835098

The relation of central 5-HT1A and 5-HT2 receptors: low dose agonist-induced selective tolerance in the rat.

M R Pranzatelli1, R S Pluchino.   

Abstract

To study the purported relation of 5-HT1A and 5-HT2 receptors, we chronically injected rats with a low dose of selective 5-HT agonists to induce behavioral tolerance and then tested for cross-tolerance. Acutely, in naive rats, both the putative 5-HT2 agonist DOI and 5-HT1A agonist 8-OH-DPAT induced some behaviors of the "serotonin syndrome" but the two drugs could be differentiated. Only DOI evoked shaking behavior, "skin jerks" (spinal myoclonus), and hyperthermia. Only 8-OH-DPAT induced flat body posture, head weaving, hypothermia, and occasional hindlimb hyperextension (dystonic posture). Both drugs, especially 8-OH-DPAT, evoked forepaw tapping. Chronic (21 day) treatment with DOI prevented DOI-evoked behaviors but not behaviors evoked by 8-OH-DPAT. Behaviors evoked by 8-OH-DPAT and not DOI decreased significantly after chronic 8-OH-DPAT treatment. Development of selective tolerance suggests that putative selective 5-HT2 and 5-HT1A agonists exert both shared and distinctive behavioral effects through separate sites whose relation is behavior-specific. For some behaviors (forepaw myoclonus, shaking behavior, thermoregulation), there is a functional interaction between 5-HT1A and 5-HT2 sites, while for other behaviors (skin jerks, flat body posture, head weaving), there is no interaction.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1835098     DOI: 10.1016/0091-3057(91)90199-c

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  11 in total

1.  A systematic investigation of the differential roles for ventral tegmentum serotonin 1- and 2-type receptors on food intake in the rat.

Authors:  Wayne E Pratt; Kara A Clissold; Peagan Lin; Amanda E Cain; Alexa F Ciesinski; Thomas R Hopkins; Adeolu O Ilesanmi; Erin A Kelly; Zachary Pierce-Messick; Daniel S Powell; Ian A Rosner
Journal:  Brain Res       Date:  2016-07-16       Impact factor: 3.252

2.  Circadian rhythm in the responsiveness of central 5-HT2A receptor to DOI in rats.

Authors:  H Nagayama; J Q Lu
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

3.  An ethopharmacological analysis of the behavioral effects of 8-OH-DPAT.

Authors:  R J Blanchard; J K Shepherd; J Armstrong; S F Tsuda; D C Blanchard
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 4.  5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions.

Authors:  J E Barrett; K E Vanover
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Circadian rhythm in the response of central 5-HT1A receptors to 8-OH-DPAT in rats.

Authors:  J Q Lu; H Nagayama
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

6.  Serotonin involvement in the discriminative stimulus effects of kappa opioids in pigeons.

Authors:  M E Bronson; Y P Lin; K Burchett; M J Picker; L A Dykstra
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Long-lasting effects of chronic stress on DOI-induced hyperthermia in male rats.

Authors:  Leslie Matuszewich; Bryan K Yamamoto
Journal:  Psychopharmacology (Berl)       Date:  2003-05-27       Impact factor: 4.530

Review 8.  5-HT1A receptor agonists: recent developments and controversial issues.

Authors:  J De Vry
Journal:  Psychopharmacology (Berl)       Date:  1995-09       Impact factor: 4.530

9.  The stimulus effects of 8-OH-DPAT: evidence for a 5-HT2A receptor-mediated component.

Authors:  C J Reissig; J R Eckler; R A Rabin; K C Rice; J C Winter
Journal:  Pharmacol Biochem Behav       Date:  2007-09-19       Impact factor: 3.533

10.  Cross-tolerance studies of serotonin receptors involved in behavioral effects of LSD in rats.

Authors:  K M Krebs; M A Geyer
Journal:  Psychopharmacology (Berl)       Date:  1994-01       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.